BridgeMD
New treatment option for Individuals at Risk of First Episode Psychosis
Official title Culturally Adapted Cognitive Behavior Therapy for Individuals At Risk of First Episode Psychosis
ClinicalTrials.gov ID: NCT07188597
What this study is testing
- What it's testing
- Young people constitute nearly half of Pakistan's population and are highly vulnerable to risk factors for mental illness, including poverty, inequality, abuse, and violence. Estimates suggest that 19-34% of children and adolescents experience emotional or behavioural disorders, though this is likely underestimated.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 35
You may be able to join if
- Male or female help-seeking individual aged 16-35 years;
- Score 6 or above on PQ-16
- Meet the at risk of FEP criteria using CAARMS Operationalized Intake Criteria based on three groups (vulnerability, attenuated psychosis or brief...
- Assessed as competent to provide informed consent.
- Give written informed consent.
You likely can't join if
- Temporary resident unlikely to be available for follow up.
- Unable to engage, participate or respond to research questionnaires.
- a history of psychotic illness (treated or untreated).
- previous treatment with an antipsychotic or mood-stabilising agent.
- active substance abuse (except nicotine or caffeine) or dependence within the last three months, according to DSM-V criteria.
The study team makes the final eligibility decision.
Where it's taking place
- Karachi, Sindh, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Karachi, Sindh, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.